Position in RCKT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,878,599
+$10,786,122 QoQ
Shares Held
3,038,715
+11433.4% QoQ
Ownership
2.78%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
11 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. RCKT ranks #52 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,099,318 | $363,731,344 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
317,058 | $141,579,078 | |
| 3 | INCY |
Incyte Corp
|
1,253,138 | $117,945,347 | |
| 4 | RPRX |
Royalty Pharma plc
|
2,120,692 | $101,729,594 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,761,437 | $81,247,039 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
628,075 | $66,199,104 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,246,943 | $62,240,320 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
1,600,168 | $61,590,466 |
All Filings in RCKT
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,878,599 | 3,038,715 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $92,477 | 26,347 | Shares | Other | 2026-02-13 | |
| 2025-03-31 | $2,925,575 | 438,617 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $5,741,498 | 456,762 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $186,547 | 10,100 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $421,621 | 19,583 | Shares | Other | 2024-08-14 | |
| 2022-12-31 | $264,195 | 13,500 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $1,625,621 | 101,856 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $189,888 | 13,800 | Shares | Other | 2022-08-15 | |
| 2021-12-31 | $2,086,270 | 95,569 | Shares | Other | 2022-02-14 | |
| 2020-12-31 | $1,940,787 | 35,390 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||